Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep260 | Endocrine-Related Cancer | ECE2024

Carcinoid heart disease - a single centre experience

Kurzyńska Anna , Stefańska Agnieszka , Kolasa Magdalena , Sowa Staszczak Anna , Hubalewska-Dydejczyk Alicja

Carcinoid heart disease (CHD) affects about 20-50% of patients with carcinoid syndrome (CS) and is the main cause of mortality in this group of patients. The 3-year survival rate in patients with CHD is 31% compared to 68% in those without cardiac involvement. The cause of the development of CHD is the flow of serotonin-rich blood, and the lesions affect the right heart (localizing mainly in the endocardium and inner membrane of large vessels). The study aim was to present a s...

ea0090ep27 | Adrenal and Cardiovascular Endocrinology | ECE2023

Metanephrines work-up in patients diagnosed with incindentaloma - the influence of commonly used drugs on results interpretation

Kokoszka Joanna , Opalinska Marta , Kolasa Magdalena , Szewczyk Monika , Sitarz Katarzyna , Bugajska Jolanta , Berska Joanna , Sztefko Krystyna , Hubalewska-Dydejczyk Alicja

Introduction: Due to the frequent occurrence of adrenal incidentalomas, diagnosis of their hormonal activity is a significant clinical concern. Approximately 7-10% of adrenal tumors are pheochromocytomas, which even in silent form can lead to hemodynamic instability during surgery. According to the ESE and ENSAT guidelines in any case of adrenal tumors greater than 1 cm pheochromocytoma should be excluded based on plasma metanephrines level and urinary metanephrines excretion....